INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

01 3 2023 07:30:35 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

14 2 2023 08:00:33 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference

08 2 2023 08:00:59 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 08:00:24 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data Presentations at the American College of Neuropsychopharmacology 61st Annual Meeting

08 12 2022 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences

10 11 2022 08:00:03 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

03 11 2022 07:30:00 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and Webcast

27 10 2022 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 8 2022 07:30:00 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and Webcast

02 8 2022 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

13 6 2022 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

10 5 2022 07:30:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

03 5 2022 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations

25 4 2022 07:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors

21 4 2022 08:00:02 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference

05 4 2022 08:00:03 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

01 3 2022 07:30:00 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast

22 2 2022 08:00:02 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 2 2022 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

07 1 2022 16:01:00 提供 Nasdaq GlobeNewswire